BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16317433)

  • 1. Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980-1994.
    Stiller CA; Passmore SJ; Kroll ME; Brownbill PA; Wallis JC; Craft AW
    Br J Cancer; 2006 Jan; 94(1):22-9. PubMed ID: 16317433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of 41 cases of non-metastatic Ewing's sarcoma in children].
    Yuan Q; Han YL; Pan C; Tang JY; Gao YJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Apr; 26(4):365-370. PubMed ID: 38660900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of location of inpatient cancer care on patients with Ewing sarcoma and osteosarcoma-A population-based study.
    Alvarez E; Malogolowkin M; Pollock BH; Li Q; Johnston E; Marina N; Wun T; Thorpe S; Keegan T
    Pediatr Blood Cancer; 2021 Jul; 68(7):e28998. PubMed ID: 33720485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma.
    Zhan H; Mo F; Zhu M; Xu X; Zhang B; Liu H; Dai M
    Sci Rep; 2021 Nov; 11(1):22723. PubMed ID: 34811459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group.
    Cotterill SJ; Ahrens S; Paulussen M; Jürgens HF; Voûte PA; Gadner H; Craft AW
    J Clin Oncol; 2000 Sep; 18(17):3108-14. PubMed ID: 10963639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival outcomes of pediatric osteosarcoma and Ewing's sarcoma: a comparison of surgery type within the SEER database, 1988-2007.
    Schrager J; Patzer RE; Mink PJ; Ward KC; Goodman M
    J Registry Manag; 2011; 38(3):153-61. PubMed ID: 22223058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials.
    Livingston JA; Hess KR; Naing A; Hong DS; Patel S; Benjamin RS; Ludwig JA; Conley A; Herzog CE; Anderson P; Meric-Bernstam F; Kurzrock R; Subbiah V
    Oncotarget; 2016 Sep; 7(39):64421-64430. PubMed ID: 27486883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional survival is greater than overall survival at diagnosis in patients with osteosarcoma and Ewing's sarcoma.
    Miller BJ; Lynch CF; Buckwalter JA
    Clin Orthop Relat Res; 2013 Nov; 471(11):3398-404. PubMed ID: 23821136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
    Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
    BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group.
    Raciborska A; Bilska K; Drabko K; Chaber R; Sobol G; Pogorzała M; Wyrobek E; Połczyńska K; Rogowska E; Rodriguez-Galindo C; Wożniak W
    Pediatr Blood Cancer; 2014 Dec; 61(12):2170-4. PubMed ID: 25163763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparity in Outcomes for Adolescent and Young Adult Patients Diagnosed With Pediatric Solid Tumors Across 4 Decades.
    Chen I; Pasalic D; Fischer-Valuck B; Frangoul H; DeWees T; Shinohara ET; Perkins SM
    Am J Clin Oncol; 2018 May; 41(5):471-475. PubMed ID: 27841802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socio-economic patterning in early mortality of patients aged 0-49 years diagnosed with primary bone cancer in Great Britain, 1985-2008.
    Blakey K; Feltbower RG; James PW; Libby G; Stiller C; Norman P; Gerrand C; McNally RJQ
    Cancer Epidemiol; 2018 Apr; 53():49-55. PubMed ID: 29414632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ewing Sarcoma of the Head and Neck.
    Ellis MA; Gerry DR; Neskey DM; Lentsch EJ
    Ann Otol Rhinol Laryngol; 2017 Mar; 126(3):179-184. PubMed ID: 28056517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of Ewing's sarcoma of bone treated with combined modality therapy.
    Kinsella TJ; Miser JS; Waller B; Venzon D; Glatstein E; Weaver-McClure L; Horowitz ME
    Int J Radiat Oncol Biol Phys; 1991 Mar; 20(3):389-95. PubMed ID: 1995522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.
    Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncological outcomes of patients with Ewing's sarcoma: is there a difference between skeletal and extra-skeletal Ewing's sarcoma?
    Pradhan A; Grimer RJ; Spooner D; Peake D; Carter SR; Tillman RM; Abudu A; Jeys L
    J Bone Joint Surg Br; 2011 Apr; 93(4):531-6. PubMed ID: 21464495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies.
    Paulussen M; Ahrens S; Burdach S; Craft A; Dockhorn-Dworniczak B; Dunst J; Fröhlich B; Winkelmann W; Zoubek A; Jürgens H
    Ann Oncol; 1998 Mar; 9(3):275-81. PubMed ID: 9602261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Outcomes and Complications in Pediatric Ewing Sarcoma.
    Hamilton SN; Carlson R; Hasan H; Rassekh SR; Goddard K
    Am J Clin Oncol; 2017 Aug; 40(4):423-428. PubMed ID: 25599318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Pathological Fractures on the Prognosis of Primary Malignant Bone Sarcoma in Children and Adults: A Single-Center Retrospective Study of 205 Patients.
    Schlegel M; Zeumer M; Prodinger PM; Woertler K; Steinborn M; von Eisenhart-Rothe R; Burdach S; Rechl H; von Luettichau I
    Oncology; 2018; 94(6):354-362. PubMed ID: 29656296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
    Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
    Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.